Isan Chen
2017
In 2017, Isan Chen earned a total compensation of $753.8K as Executive Vice President and Chief Medical and Development Officer at Mirati Therapeutics, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,700 |
|---|---|
| Option Awards | $211,900 |
| Salary | $408,300 |
| Other | $2,920 |
| Total | $753,820 |
Chen received $408.3K in salary, accounting for 54% of the total pay in 2017.
Chen also received $130.7K in non-equity incentive plan, $211.9K in option awards and $2.9K in other compensation.
Rankings
In 2017, Isan Chen's compensation ranked 10,276th out of 14,666 executives tracked by ExecPay. In other words, Chen earned more than 29.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,276 out of 14,666 | 30th |
Division Manufacturing | 3,982 out of 5,768 | 31st |
Major group Chemicals And Allied Products | 1,400 out of 2,074 | 33rd |
Industry group Drugs | 1,138 out of 1,730 | 34th |
Industry Pharmaceutical Preparations | 887 out of 1,329 | 33rd |
Source: SEC filing on April 20, 2018.
Chen's colleagues
We found four more compensation records of executives who worked with Isan Chen at Mirati Therapeutics in 2017.